The mevalonate precursor enzyme 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1) is overexpressed in breast cancer, and a key mediator of enrichment of breast CSCs [137,138]. Here, HMGCS1 is linked to breast carcinoma.